Abstract-Ferritin plays an important role in iron detoxification and iron storage by converting soluble iron(II) to insoluble iron(III) inside the protein cage. Mechanism of in vitro ferritin iron release occurs more readily under reducing conditions, whereby reducing agents may enter into the ferritin cage through the protein pores to convert insoluble iron(III) into soluble iron(II), after accepting an electron from reducing agents. The soluble iron(II) then liberates outside the protein cage and forms coloured and stable complexes in the presence of chromophore, an iron(II) chelating agent, to be quantified by spectrophotometry. However, iron(II) is readily converted back to iron(III) in the presence of oxygen. Thus, oxygen scavenger compounds were used to remove any dissolved oxygen. Studies suggested that low concentration of chaotropic agents regulate the protein pore opening and result in protein unfolding that is therefore accessible by reducing agents more effectively. According to in vivo studies, iron exit from ferritin for recycling or meeting the cell's need via lysosomal and/or proteasomal pathways. We designed an assay to determine the total iron available inside the ferritin by first using the commercially available iron(II) or iron(III) compounds as a substrate to optimize the concentration of reactants involved. Apart from chromophore and reducing agents, oxygen scavenger compounds, chaotropic agents and enzymes were added in order to induce ferritin iron release effectively. Linear calibration curve of the iron(II)-chromophore complex were obtained and was used as a reference to correlate absorbance readings to concentration of iron level. Reducing agents was able to reduce the iron(III) to iron(II) and oxygen scavenger A seems to be more effective in removing any dissolved oxygen to avoid oxidation of both the reducing agents and iron(III). Taken altogether, this experiment setup will be beneficial for the improvement of efficiency in quantifying the total iron level inside the ferritin.
I. MATERIALS AND METHODS
Commercially available lyophilized human liver ferritin was purchased from Lee Biosolutions. Chromophores, reducing agents and other chemicals were obtained from Sigma or Merck, and were of analytical reagent grade. The spectrophotometric analysis was performed in Lambda 25 UV/Vis Spectrophotometers, Perkin Elmer and VersaMax Microplate Reader, Molecular Devices. All reactions were conducted at room temperature.
A. Standard calibration curve
Iron(II) substrate was added to the reactant (chromophore) in buffer pH 7.0. Spectrophotometric analysis between 400-700 nm was carried out immediately. A calibration curve of iron(II) was constructed to optimize the optimum chromophore concentration needed to achieve spontaneous reaction. The amount of iron(II) was calculated using Beer-Lambert Law.
A= -log 10 (I/I 0 ) = εcl.
(1)
The above equation is based on the Beer-Lambert law, which is widely used in quantitative analysis. The absorbance, A, is directly proportionate to the concentration, c, of the compound measured, the path length of the sample, l, and the molar absorption coefficient, ε, a wavelength-dependent constant characteristics of the compound. I 0 , is the incident light intensity and I, is the transmitted light intensity. All compounds do absorb some of the light that falls upon them giving them the energy to excite the electrons of the compound to a higher energy level. The photometer was calibrated using a standard compound and background noise was taken into account.
B. Iron release from human liver ferritin
In this section, the iron content of human liver ferritin was determined by inductive-coupled plasma-mass spectrometry (ICP-MS). Iron(III) compound was used to construct the calibration curve in order to determine the optimized concentration of reducing agents.
Iron release of human liver ferritin was induced and facilitated by opening ferritin cages with the addition of reducing agents, chaotropic agents and enzymes. The recovery of ferritin iron release was compared with results from elementary analysis by ICP-MS.
II. RESULTS

A. Standard calibration curve
By spectrophotometric analysis, the concentration of coloured iron(II)-chromophore complexes in solution can be easily determined by correlating the absorbance readings with a standard curve. Therefore, a standard curve was constructed as a reference to determine the iron(II) level in an unknown sample. 
B. Optimization of chromophore concentration
Concentration of chromophore was determined using iron(II) compound in order to attain the optimum concentration that is sufficient to form coloured iron(II)-chromophore complexes with available iron(II) in a solution. In order to facilitate the optimization purposes, microplate well was used to perform each assay in triplicates. Iron(II) in a range of 50-3000 µg/L was used to optimize the optimum concentration of chromophore at pH 7.4. Fig 3 shows the stability of iron(II)-chromophore complex within a 30 minutes time period. For iron(II) amount with 50 µg/L, there were significant variations in two chromophore concentrations, especially in 1.0 mM and 2.0 mM, at 20 minutes and 10 minutes, respectively. However, in the higher iron(II) amounts, 1000 µg/L, 2000 µg/L and 3000 µg/L, the stability of iron(II)-chromophore complex was almost consistent throughout the absorbance readings. These results suggested that higher concentration of chromophore in lower iron(II) concentration has a tendency to overwhelm the reaction system. On the other hand, higher iron(II) concentration will definitely require higher chromophore concentration, therefore, resulting in the complex to be almost stable throughout the entire experimental time. 
C. Reduction effectiveness
Studies have showed that reducing agent A is effective enough to liberate iron(II) from insoluble iron(III) inside the ferritin cage, whereby reducing agent A reduces both compound A and compound B simultaneously. Therefore, the effectiveness of reducing agent A can be confirmed by examining the changes of the maximum absorption peaks, respectively. Shorter path-light cuvette was used to resolve higher concentrations of the specific compound. Fig 4 shows the changes of the absorbance readings of maximum absorption peaks in compound A and compound B, respectively. Concentrations of both compound A and compound B decreased over time indicating the production of reducing agents. Optimum concentration of both compound A and compound B was used to induce ferritin iron release. 
D. Optimization of reducing agent A concentration
Concentration of reducing agent A was determined using iron(III) compound and optimized chromophore concentration in order to attain the optimum concentration that is sufficient to induce the liberation of soluble iron(II) from insoluble iron(III) inside the ferritin cage. Iron(III) in a range of 50-3000 µg/L was used to optimize the optimum concentration of the reducing agents at pH 7.4. Fig 5 shows the stability of iron(II)-chromophore complex within 30 minutes after iron(III) was converted to iron(II) by the reducing agents followed by the formation of iron(II)-chromophore complex in the presence of 1.0 mM chromophore. Lower iron(III) amount might require relatively lower concentration of reducing agents to attain the stability of the complex formed. However, in higher reducing agents concentration as in 500 µg/L of iron(III), the absorbance fluctuated, suggesting that the complex was not stable, probably due to the excessive unused reducing agents in the assay, which may be detrimental to the iron(II)-chromophore complex formed. 
E. Effect of oxygen scavenger system
Oxygen scavenger was added to each assay to minimize the oxidization of iron(II) to iron(III). Additionally, the oxygen scavenger also played a crucial role to avoid reducing agent A from being oxidized in this experiment setup. Therefore, oxygen scavenger was added to remove dissolved oxygen that was introduced unintentionally during the buffer preparation and experiment setup. Iron(III) in the range of 50-3000 µg/L was used. Fig 6 shows the stability of iron(II)-chromophore complex within 30 minutes after iron(III) was converted to iron(II) by the reducing agents followed by the formation of the iron(II)-chromophore complex in the presence of the chromophore and the oxygen scavenger A. As compared to Fig 5 (without the oxygen scavenger), Fig 6 shows improvement in the stability of the iron(II)-chromophore complex in 50 µg/L and 500 µg/L iron(III) respectively. Also, improvement in the stability of the iron(II)-chromophore complex in both 2000 µg/L and 3000 µg/L iron(III), but not in 0.5 mM reducing agents concentrations that probably overwhelmed the reaction system as time elapsed. Fig 7 shows the stability of iron(II)-chromophore complex within 30 minutes after iron(III) was converted to iron(II) by the reducing agents followed by formation of the iron(II)-chromophore complex in the presence of chromophore and oxygen scavenger B. We observed an unstable iron(II)-chromophore complex in the presence of oxygen scavenger B, especially in the presence of higher reducing agents concentrations. Oxygen scavenger B not only prevented the oxidation of iron(III) to iron(II) and the reducing agents, but required less reducing agents for its purposes. 
F. Reducing potential of additional chaotropic agents
Chaotropic reagents were used to regulate the pore opening of ferritin protein to facilitate the entry of reducing agents more effectively. Therefore, the chaotropic reagents must not have any reducing potential. This was to ensure that the conversion of iron(III) to iron(II) was only directed by the reducing agents. To evaluate the chaotropic agents' reducing potential, assays in the presence chromophore, one chaotropic agents and iron(III) were scanned. Fig 8 shows the reducing potential of the chaotropic agents used. Both chaotropic agent A and B showed no spectra curve at the maximum absorbance at 562 nm, therefore, these reagents had no reducing potential. However, chaotropic agent C showed spectra curve with maximum absorbance at 562 nm, similar to Fig 1, suggesting that chaotropic agent C has a reducing potential. Chaotropic agent C was eliminated from further downstream applications. 
III. CONCLUSION
Calibration curve of iron(II)-chromophore complex could be used as a reference to correlate absorbance readings to concentration of iron levels. Reducing agents can reduce the iron(III) to iron(II), which will later combine with chromophore to form iron(II)-chromophore complex to be detected by a spectrophotometer. Oxygen scavenger system will remove any dissolved oxygen to avoid oxidation of both reducing agents and iron(III) in this experiment setup. Taken altogether, this assay will be beneficial for the improvement of efficiency in quantifying the total iron levels.
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